KnowHow: The FDB Blog

Pill Bottles

2014 Update: Demystifying Source NDC Codes, Repackaged Products and Biosimilars

Corporate Perspective, FDA, Standards
Thursday, October 23, 2014
by Julie Suko, PharmD

It’s time for the 2014 update to what the FDB marketing department informs me on a regular basis is the most popular FDB blog topic of all time. Read More

Rising Tide

Are You Prepared to Meet the Rising Tide of Boxed Warning Drugs?

Corporate Perspective
Tuesday, September 23, 2014
by Christine Cheng, PharmD

What do antidepressants, antipsychotic drugs, smoking cessation agents, non-steroidal anti-inflammatory drugs (NSAIDs) have in common? All of these drugs have the FDA’s highest warning: the boxed warning. Read More

I Heart HealthIT

Moving Toward EHR Interoperability is Something to Be Happy About

Corporate Perspective, Transformational Change, Government, Standards
Friday, September 12, 2014
by Tom Bizzaro, RPh

It’s National Health IT Week once again which has prompted me to start thinking about how far IT has come and how far it needs to go in healthcare. Read More

Welcome to Drug Knowledge


What if drug data was more than just data? > Visit the Media Centre for more videos.

Media Centre >